We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Phase 2a Study to Evaluate the Safety and Tolerability of MEDI-563 in Adults With Asthma (MEDI-563)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00783289
Recruitment Status : Completed
First Posted : October 31, 2008
Last Update Posted : August 29, 2012
Information provided by (Responsible Party):
MedImmune LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2009
  Study Completion Date : December 2009
  Certification or Request for Extension to Delay Results Submission: June 28, 2012